CONSTITUTIVE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) BIOSYNTHESIS IN HUMAN HEP-G2 HEPATOMA-CELLS IS MAINTAINED BY AN AUTOCRINE FACTOR

被引:0
|
作者
BERGONZELLI, GE
KRUITHOF, EKO
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We studied the production of PAI-1 by human Hep G2 hepatoma cells. When culturing these cells in fresh medium (FM), PAI-1 accumulation rate was not linear: PAI-1 antigen after 24 h was 200 ng/10(6) cells while in subsequent 24 h periods, it was on average 1,000 ng/10(6) cells. Culture of Hep G2 cells in regular changes of a 12 h conditioned medium (CM) obtained from other Hep G2, instead of in FM, resulted in a 2-fold higher PAI-1 accumulation. In cells incubated in FM, PAI-1 mRNA declined rapidly after medium change and returned to basal levels after 24 h. In contrast, PAI-1 mRNA remained relatively stable when CM was used. The acute phase mediator interleukin 6 (IL-6) was not responsible for the autocrine stimulation of PAI-1: neither IL-6 nor antibodies to IL-6 altered the observed variations in PAI-1 expression. Our studies suggest the presence of an unknown PAI-1 stimulating factor.
引用
收藏
页码:222 / 225
页数:4
相关论文
共 50 条
  • [1] STABILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    LINDAHL, TL
    SIGURDARDOTTIR, O
    WIMAN, B
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (02) : 748 - 751
  • [2] THE ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) OF HUMAN PLATELET
    BOOTH, NA
    CROLL, A
    BENNETT, B
    FIBRINOLYSIS, 1990, 4 : 138 - 140
  • [3] EFFECT OF LOW-DENSITY LIPOPROTEINS ON SECRETION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) BY HUMAN ENDOTHELIAL-CELLS AND HEPATOMA-CELLS
    LATRON, Y
    ALESSI, MC
    ANFOSSO, F
    NALBONNE, G
    LAFONT, H
    PORTUGAL, H
    JUHANVAGUE, I
    FIBRINOLYSIS, 1990, 4 : 82 - 83
  • [4] PARTIAL CHARACTERIZATION OF A PLASMINOGEN-ACTIVATOR INHIBITOR-1 STIMULATING FACTOR PRODUCED BY HUMAN HEPATOMA-CELLS
    BERGONZELLI, GE
    KRUITHOF, EKO
    FIBRINOLYSIS, 1993, 7 (05) : 335 - 340
  • [5] Plasminogen-activator inhibitor-1 in (PAI-1) gastric cancer
    Tabuchi, Y
    Nakamura, T
    Miyamura, K
    Nakae, S
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 447 - 450
  • [6] ROLE OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN DIC
    MATSUDA, T
    ASAKURA, H
    SAITO, M
    JOKAJI, H
    UOTANI, C
    KUMABASHIRI, I
    MORISHITA, E
    YAMAZAKI, M
    THROMBOSIS RESEARCH, 1991, 63 (02) : 269 - 269
  • [7] PLASMINOGEN-ACTIVATOR INHIBITOR-1(PAI-1) AND TISSUE-PLASMINOGEN ACTIVATOR PLASMINOGEN-ACTIVATOR INHIBITOR-1(TPA-PAI-1) IN IDDM - PROFILE BY COMPLICATIONS
    SUMINSKI, R
    DASILVA, S
    SMITH, M
    ERBEY, J
    DIABETES, 1994, 43 : A197 - A197
  • [8] REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    CIRCULATION, 1990, 82 (04) : 601 - 601
  • [9] REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    ARTERIOSCLEROSIS, 1990, 10 (05): : A909 - A909
  • [10] GEMFIBROZIL INHIBITS THE SYNTHESIS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN RAT HEPATOMA-CELLS
    ZEHEB, R
    MINK, PA
    GELEHRTER, TD
    CLINICAL RESEARCH, 1990, 38 (02): : A470 - A470